Healthcare • Medical Devices
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ECOR is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
4 top institutions tracked
Sentiment: neutral
Last trade: buy 23 days ago
Red flags: 4
32 filers reported a long position in ECOR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.8M | 211.6K | +4.4% |
| FourWorld Capital Management LLC | $812.2K | 94K | New |
| WEXFORD CAPITAL LP | $795.4K | 92.1K | New |
| GEODE CAPITAL MANAGEMENT, LLC | $632.2K | 73.1K | -6.3% |
| NORTHERN TRUST CORP | $574.6K | 66.5K | +498.2% |
| JANE STREET GROUP, LLC | $547.8K | 63.4K | New |
| Wealthspire Advisors, LLC | $410.4K | 47.5K | Unchanged |
| CITADEL ADVISORS LLC | $378.5K | 43.8K | New |
| MARSHALL WACE, LLP | $377.3K | 43.7K | New |
| VANGUARD FIDUCIARY TRUST CO | $335K | 38.8K | +0.6% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.